Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Probiotic Supplementation in Extremely Preterm Infants in Scandinavia: A Double-blinded Randomized Controlled Multicenter Trial to Reduce the Risk of Necrotizing Enterocolitis and Mortality

NCT05604846 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.

NCT NCT05604846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05604846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Probiotic Supplementation in Extremely Preterm Infants in Scandinavia: A Double-blinded Randomized Controlled Multicenter Trial to Reduce the Risk of Necrotizing Enterocolitis and Mortality
Lead sponsor
Region Stockholm
Phase
Not applicable
Overall status
Recruiting
Start date
December 16, 2022
Completion date
December 31, 2026
Enrollment
1,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

death, feeding disorder neonatal, growth acceleration, necrotizing enterocolitis, sepsis newborn